Wall Street analysts predict that Brickell Biotech, Inc. (NASDAQ:BBI – Get Rating) will report sales of $190,000.00 for the current quarter, according to Zacks. Three analysts have made estimates for Brickell Biotech’s earnings. The lowest sales estimate is $130,000.00 and the highest is $300,000.00. Brickell Biotech reported sales of $20,000.00 during the same quarter last […]
Analysts expect Brickell Biotech, Inc. (NASDAQ:BBI – Get Rating) to announce earnings of ($0.06) per share for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Brickell Biotech’s earnings. The lowest EPS estimate is ($0.07) and the highest is ($0.05). Brickell Biotech reported earnings per share of ($0.15) during the same […]
Zacks Investment Research upgraded shares of Brickell Biotech (NASDAQ:BBI – Get Rating) from a hold rating to a buy rating in a report released on Wednesday, Zacks.com reports. Zacks Investment Research currently has $0.25 price target on the stock. According to Zacks, “Brickell Biotech, Inc. is a clinical-stage pharmaceutical company. It is focused on developing […]
Brokerages forecast that Brickell Biotech, Inc. (NASDAQ:BBI – Get Rating) will post earnings per share of ($0.08) for the current quarter, according to Zacks. Three analysts have issued estimates for Brickell Biotech’s earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.12). Brickell Biotech posted earnings per share of ($0.15) during the same […]
Equities research analysts expect that Brickell Biotech, Inc. (NASDAQ:BBI – Get Rating) will post sales of $270,000.00 for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Brickell Biotech’s earnings. The highest sales estimate is $400,000.00 and the lowest is $130,000.00. Brickell Biotech reported sales of $20,000.00 in the same […]